Characterization and survival of patients with Hodgkin lymphoma. A 7-Year single-center study
Original Research
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Fanny Viviana Quinte Guaiña, Rosa Nohemí Terán Terán, Rommel Espinoza de los Monteros

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
DOI:
https://doi.org/10.33821/630Keywords:
Hodgkin Disease, Lymphoma AIDS-Related, /mortality, Hospital Mortality, Mortality Registries, SURVIVAL ANALYSISAbstract
Introduction: Hodgkin's Lymphoma (HL) is a rare hematological neoplasm where neoplastic cells form a minority of the tumor and are surrounded by a reactive inflammatory medium that includes lymphocytes eosinophils, neutrophils, histiocytes, and plasma cells. The objective of the present study was to describe a population with this pathology and its survival in 7 years of follow-up.
Methodology: This longitudinal study was carried out at the Carlos Andrade Marín Hospital, in Quito, Ecuador, from 2013-2019, with a non-probabilistic sample of patients with HL. Demographic, clinical, laboratory variables, Ann Arbor classification, histological classification, treatment and response, mortality, and survival time were recorded. Descriptive statistics are used; bivariate and survival analysis.
